FDA
approval
· 2020-08-07
FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Exelan Pharmaceuticals, Inc.)
Summary
The FDA granted a supplemental approval for the lisinopril and hydrochlorothiazide tablets from Exelan Pharmaceuticals.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS)